Keyword Suggestion
Domain Informations
Newbiotherapeutics.com lookup results from grs-whois.hichina.com server:
- Domain created: 2011-04-06T11:46:54Z
- Domain updated: 2024-08-08T06:02:08Z
- Domain expires: 2025-04-06T11:46:54Z 0 Years, 143 Days left
- Website age: 13 Years, 222 Days
- Registrar Domain ID: 1649484130_DOMAIN_COM-VRSN
- Registrar Url: http://www.net.cn
- Registrar WHOIS Server: grs-whois.hichina.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +86.95187
- Name server:
- DNS25.HICHINA.COM
- DNS26.HICHINA.COM
Administrator
- name : Li Xuesong
- address : BOE Science Park, 10 Jiuxianqiao Road, Chaoyang,Beijing 100016, China
- country : CN
- phone : +86-10-84562121
- fax : +86-10-84564234
- email : [email protected]
- handle : ML2382-AP
- mnt-by : MAINT-CNNIC-AP
- last-modified : 2014-12-26T06:30:02Z
- source : APNIC
Technical support
- name : Cao Wentao
- address : BOE Science Park, 10 Jiuxianqiao Road, Chaoyang,Beijing 100016, China
- country : CN
- phone : +86-10-84562121
- fax : +86-10-84564234
- email : [email protected]
- handle : BW667-AP
- mnt-by : MAINT-CNNIC-AP
- last-modified : 2014-12-26T06:30:02Z
- source : APNIC
Network
- inetnum : 120.133.0.0 - 120.133.255.255
- name : CHINA-21VIANET
- country : CN
- abuse-c : AC1601-AP
- status : ALLOCATED PORTABLE
- mnt-by : MAINT-CNNIC-AP
- mnt-lower : MAINT-CN-21VIANET
- mnt-routes : MAINT-CNNIC-AP
- mnt-irt : IRT-CNNIC-CN
- last-modified : 2021-06-16T01:30:07Z
- source : APNIC
Owner
- organization : 21ViaNet(China),Inc.
- address : BOE Science Park, 10 Jiuxianqiao Road, Chaoyang,,Beijing 100016, China
Domain Provider | Number Of Domains |
---|---|
godaddy.com | 286730 |
namecheap.com | 101387 |
networksolutions.com | 69118 |
tucows.com | 52617 |
publicdomainregistry.com | 39120 |
whois.godaddy.com | 32793 |
enomdomains.com | 23825 |
namesilo.com | 21429 |
domains.google.com | 21384 |
cloudflare.com | 20573 |
gmo.jp | 18110 |
name.com | 17601 |
fastdomain.com | 14708 |
register.com | 13495 |
net.cn | 12481 |
ionos.com | 12416 |
ovh.com | 12416 |
gandi.net | 12305 |
registrar.amazon.com | 12111 |
Host Informations
- IP address: 120.133.3.203
- Location: China
- Latitude: 34.7725
- Longitude: 113.7266
- Timezone: Asia/Shanghai
Site Inspections
Port Scanner (IP: 120.133.3.203)
Spam Check (IP: 120.133.3.203)
Recent Searched Sites
› Canglobalcanada.ca (1 mins ago) / CA
› Simonsen-jefferson-2.hubstack.net (6 seconds ago) / US
› Bridgewater-hall.co.uk (13 seconds ago) / US
› Healthcriticreport.com (5 seconds ago) / US
› Newbiotherapeutics.com (0 seconds ago) / CN
› Caribbeankeppelbay.com (29 seconds ago) / CA
› Goodegginvestments.com (26 seconds ago) / US
› Ahatpa.com (48 seconds ago) / US
› Corsunits.org (18 seconds ago) / ES
› Chippendalegolf.com (27 seconds ago) / US
› Filmy4wap.gen.in (25 seconds ago) / US
› Dosmareshotel.com (1 mins ago) / US
› Corsi.vigamusacademy.com (30 seconds ago) / IT
› Warships.acetech.cloud (15 seconds ago) / US
› Jiuzhai.com (41 seconds ago) /
› Artimator.io (2 seconds ago) / US
› Correctgbedu.com (1 mins ago) / CA
› Greenwood.aero (16 seconds ago) / US
› Infinitecampus.com (48 seconds ago) / US
› Hubz.ua (26 seconds ago) / UA
Websites Listing
We found Websites Listing below when search with newbiotherapeutics.com on Search Engine
David Yeomans - Founder - NewBio, Inc.
Web Sep 20, 2014 · Dr. David C. Yeomans, PhD, is a Professor in the Department of Anesthesia at Stanford Medical School. He is also …
Linkedin.comSynthetic Biology for Neurotherapeutics - Renew …
Web Renew Biopharma unlocking an extensive pipeline of proprietary therapeutics targeting pain management, neurodegenerative diseases & traumatic brain injuries
Renewbiopharma.comNewBio - Crunchbase Company Profile & Funding
Web Biotechnology Health Care Life Science Headquarters Regions San Francisco Bay Area, West Coast, Western US Founded Date 2021 Operating Status Active Company Type …
Crunchbase.comBio-Therapeutic
Web Bio-Therapeutic’s professional skin care technology offerings include comprehensive microcurrent facial toning systems, wet/dry microdermabrasion, microexfoliation, and a …
Bio-therapeutic.comLanier Biotherapeutics: We discover and develop antibody …
Web Lanier Biotherapeutics targets four major verticals: Multi-functional Retina, Type 2 Inflammation, Dermatology, and ImmunoOncology.
Lanierbio.comBiotherapeutic products
Web A major industrial application of biotechnology is in the development and preparation of biological medicinal products using genetically engineered bacteria, yeast, fungi, cells or …
Who.intNew Biotic
Web Though Amyotrophic Lateral Sclerosis (ALS) still only affects a proportionately small amount of the population, its effects are devastating. There is still mystery surrounding this …
Newbiotic.comPsyBio Therapeutics Establishes Research and Development
Web Jan 5, 2022 · PsyBio Therapeutics Expands Upon Previously Established Research Collaboration with Miami University. OXFORD, Ohio and COCONUT CREEK, Fla., Jan. …
Newswire.caEvox Therapeutics Acquires Exosome AAV Technology and …
Web Jun 20, 2023 · Evox Therapeutics Acquires Exosome AAV Technology and Intellectual Property - read this article along with other careers information, tips and advice on BioSpace
Biospace.comUnited Therapeutics opens a net zero energy center in RTP | WRAL …
Web Jun 14, 2023 · Editor’s note: LimeLight is a regular feature from WRAL TechWire offering another means of publishing noteworthy news. Be sure to check out more LimeLight …
Wraltechwire.comAeglea BioTherapeutics Announces Grant of Inducement Awards
Web 16 hours ago · By signing up you agree to receive content from us. Our newsletters contain tracking pixels to help us deliver unique content based on each subscriber's engagement …
Prnewswire.comTalaris Therapeutics to merge with Tourmaline Bio - BioTuesdays
Web Jun 22, 2023 · Talaris Therapeutics (NASDAQ:TALS) and closely-held Tourmaline Bio agreed to merge in an all-stock transaction. The combined company will focus on
Biotuesdays.comTalaris Therapeutics and Tourmaline Bio Announce Merger
Web 2 days ago · Merger to create Nasdaq-listed, late-stage clinical biotechnology company focused on developing Tourmaline’s anti-IL-6 antibody (TOUR006) in thyroid eye...
Globenewswire.comAeglea BioTherapeutics Announces Acquisition of Spyre …
Web 2 days ago · Acquisition of Spyre and concurrent oversubscribed $210 million private investment positions the company to advance a leading inflammatory bowel disease …
Finance.yahoo.comSonnet BioTherapeutics Announces Regulatory Approval for …
Web Jun 20, 2023 · Clinical trial was approved by the Bellberry Human Research Ethics Committee (HREC) in Australia The combination of Sonnet's SON-1010 and Roche's …
Finance.yahoo.comAeglea BioTherapeutics Inc. - Aeglea BioTherapeutics Announces …
Web Jun 23, 2023 · Aeglea BioTherapeutics, Inc. ("Aeglea") (NASDAQ: AGLE) today announced that, in connection with the acquisition of Spyre Therapeutics, Inc. ("Spyre"), a majority of …
Aeglea2020ir.q4web.com
Domains Expiration Date Updated
Site | Provider | Expiration Date |
---|---|---|
ample-shop.com | key-systems.net | -1 Years, -143 Days |
embedd.com | psi-usa.info | -2 Years, -130 Days |
shoresjardine.com | tucows.com | -1 Years, -196 Days |
tigerdirect.ca | markmonitor.com | -1 Years, -174 Days |
fordbelt.com | dynadot.com | -2 Years, -87 Days |
watersidearts.org | gandi.net | -2 Years, -60 Days |
kudangroup.com | godaddy.com | -2 Years, -36 Days |
buenatool.com | domain.com | -1 Years, -363 Days |
wilmawastiau.com | godaddy.com | 210 Days |
alldayeveryday.com | networksolutions.com | -2 Years, -124 Days |